1)Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 38:232-243, 1976
2)Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int 60:337-350, 2010
3)The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202-209, 2014
4)Kaizaki Y, Sakurai S, Chong JM, et al. Atrophic gastritis, Epstein-Barr virus infection, and Epstein-Barr virus-associated gastric carcinoma. Gastric Cancer 2:101-108, 1999
5)Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach:de novo and metachronous gastric remnant carcinoma. J Gastroenterol 40:570-577, 2005
6)海崎泰治,細川治,宮永太門,他.リンパ球浸潤胃癌─病理の立場から.胃と腸 45:1916-1925, 2010
7)宮永太門,海崎泰治,細川治,他.特殊型胃癌の臨床的特徴─胃癌取扱い規約第14版をうけて.胃と腸 45:1882-1893, 2010
8)Yanai H, Nishikawa J, Mizugaki Y, et al. Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc 45:236-242, 1997
9)Nishikawa J, Yanai H, Mizugaki Y, et al. Hypoechoic submucosal nodules:a sign of Epstein-Barr virus-associated early gastric cancer. J Gastroenterol Hepatol 13:585-590, 1998
10)Saju P, Murata-Kamiya N, Hayashi T, et al. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol 1:16026, 2016